JP2013508348A5 - - Google Patents

Download PDF

Info

Publication number
JP2013508348A5
JP2013508348A5 JP2012534793A JP2012534793A JP2013508348A5 JP 2013508348 A5 JP2013508348 A5 JP 2013508348A5 JP 2012534793 A JP2012534793 A JP 2012534793A JP 2012534793 A JP2012534793 A JP 2012534793A JP 2013508348 A5 JP2013508348 A5 JP 2013508348A5
Authority
JP
Japan
Prior art keywords
fatty acid
oil mixture
dha
epa
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012534793A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013508348A (ja
JP6116905B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2010/002854 external-priority patent/WO2011048493A1/en
Publication of JP2013508348A publication Critical patent/JP2013508348A/ja
Publication of JP2013508348A5 publication Critical patent/JP2013508348A5/ja
Application granted granted Critical
Publication of JP6116905B2 publication Critical patent/JP6116905B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012534793A 2009-10-23 2010-10-22 脂肪酸油混合物の被覆型カプセル剤および錠剤 Active JP6116905B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US25429609P 2009-10-23 2009-10-23
US25429309P 2009-10-23 2009-10-23
US25429109P 2009-10-23 2009-10-23
US61/254,291 2009-10-23
US61/254,293 2009-10-23
US61/254,296 2009-10-23
PCT/IB2010/002854 WO2011048493A1 (en) 2009-10-23 2010-10-22 Coated capsules and tablets of a fatty acid oil mixture

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015147073A Division JP6151317B2 (ja) 2009-10-23 2015-07-24 脂肪酸油混合物の被覆型カプセル剤および錠剤

Publications (3)

Publication Number Publication Date
JP2013508348A JP2013508348A (ja) 2013-03-07
JP2013508348A5 true JP2013508348A5 (enExample) 2017-02-02
JP6116905B2 JP6116905B2 (ja) 2017-04-19

Family

ID=43899870

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2012534793A Active JP6116905B2 (ja) 2009-10-23 2010-10-22 脂肪酸油混合物の被覆型カプセル剤および錠剤
JP2015147073A Active JP6151317B2 (ja) 2009-10-23 2015-07-24 脂肪酸油混合物の被覆型カプセル剤および錠剤
JP2017102240A Active JP6835664B2 (ja) 2009-10-23 2017-05-24 脂肪酸油混合物の被覆型カプセル剤および錠剤

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2015147073A Active JP6151317B2 (ja) 2009-10-23 2015-07-24 脂肪酸油混合物の被覆型カプセル剤および錠剤
JP2017102240A Active JP6835664B2 (ja) 2009-10-23 2017-05-24 脂肪酸油混合物の被覆型カプセル剤および錠剤

Country Status (9)

Country Link
US (1) US9370493B2 (enExample)
EP (1) EP2490678B1 (enExample)
JP (3) JP6116905B2 (enExample)
KR (4) KR101904388B1 (enExample)
CN (1) CN102724972A (enExample)
AU (1) AU2010309517B2 (enExample)
CA (1) CA2781525C (enExample)
ES (1) ES2895477T3 (enExample)
WO (1) WO2011048493A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9532963B2 (en) 2009-03-09 2017-01-03 Pronova Biopharma Norge As Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof
ES2661812T3 (es) 2009-10-16 2018-04-04 Mochida Pharmaceutical Co., Ltd. Composiciones
KR101904388B1 (ko) * 2009-10-23 2018-10-05 프로노바 바이오파마 너지 에이에스 지방산 오일 혼합물의 코팅된 캡슐 및 정제
AR082930A1 (es) * 2010-09-08 2013-01-16 Pronova Biopharma Norge As Composiciones que comprenden una mezcla oleosa de acidos grasos, un tensioactivo y una estatina
KR20130139896A (ko) * 2010-09-08 2013-12-23 프로노바 바이오파마 너지 에이에스 유리산 형태의 epa 및 dha, 계면활성제, 및 스타틴을 포함하는 조성물
KR20130103521A (ko) * 2010-09-08 2013-09-23 프로노바 바이오파마 너지 에이에스 지방산 오일 혼합물, 유리 지방산, 및 스타틴을 포함하는 조성물
US8697676B2 (en) 2011-06-15 2014-04-15 Ronald E Rosedale Omega-3 fatty acid nutriceutical composition and optimization method
CN107050457A (zh) 2012-01-06 2017-08-18 翁特拉制药公司 游离酸形式的ω‑3多不饱和脂肪酸的富含dpa组合物
US20160228397A1 (en) 2012-03-30 2016-08-11 Sancilio & Company, Inc. Omega-3 fatty acid ester compositions
US9480651B2 (en) 2012-03-30 2016-11-01 Sancilio & Company, Inc. Omega-3 fatty acid ester compositions unitary pharmaceutical dosage forms
US10898458B2 (en) 2012-03-30 2021-01-26 Micelle Biopharma, Inc. Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states
EP2830602B1 (en) 2012-03-30 2020-10-21 Micelle BioPharma, Inc. Omega-3 fatty acid ester compositions
EP2846779A4 (en) 2012-05-07 2015-12-16 Omthera Pharmaceuticals Inc STATIN AND OMEGA-3 FATTY ACID COMPOSITIONS
CN104968215B (zh) * 2012-12-12 2018-09-11 罗纳德·罗斯代尔 ω-3脂肪酸营养药组合物和优化方法
KR101534494B1 (ko) * 2014-01-09 2015-07-07 충남대학교산학협력단 Ｄｈａ를 포함하는 혈관 질환 예방 및 치료용 약학적 조성물
JP6514720B2 (ja) * 2015-01-21 2019-05-15 持田製薬株式会社 ω３脂肪酸の自己乳化組成物
MA41611A (fr) * 2015-02-23 2018-01-02 Omthera Pharmaceuticals Inc Préparations en milli-capsules comprenant des acides gras polyinsaturés libres
WO2016179137A1 (en) * 2015-05-04 2016-11-10 Cytometix, Inc. Compositions and methods for delivery of polyunsaturated fatty acid derivatives and analogs
JP6738477B2 (ja) * 2016-03-16 2020-08-12 ゴールデン オメガ ノルウェー アーエス ω−３脂肪酸誘導体を含む粉末及び錠剤、ならびにその製造方法
AU2017301077B2 (en) * 2016-08-12 2022-07-07 Pharmako Biotechnologies Pty Limited Omega-3 compositions and methods relating thereto
EP3768094B1 (en) 2018-03-15 2024-05-01 R.P. Scherer Technologies, LLC Enteric softgel capsules
TR201915787A2 (tr) * 2019-10-14 2021-04-21 Yilmaz Usta Duygu Bosentan monohi̇drat yüklenmi̇ş sivi kendi̇li̇ği̇nden nanoemülsi̇fi̇ye i̇laç taşiyici si̇stem ve tablet formülasyonu
CN111067876B (zh) * 2019-12-04 2022-08-16 宁夏大学 一种α-亚麻酸双层片及其制备方法
WO2025234509A1 (ko) * 2024-05-08 2025-11-13 코스맥스바이오 주식회사 pH 의존성 필름 조성물
WO2026017043A1 (zh) * 2024-07-16 2026-01-22 成都国为生物医药有限公司 一种调释型药物组合物及其用途

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8819110D0 (en) 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
ATE113471T1 (de) * 1989-08-17 1994-11-15 Cortecs Ltd Arzneiformulierungen.
JPH06181725A (ja) * 1992-12-17 1994-07-05 Kiteii:Kk 易酸化性油状物の固形化剤
JP2004135681A (ja) * 1993-11-10 2004-05-13 Yakken:Kk 食品組成物
JPH07255436A (ja) * 1994-03-25 1995-10-09 Kiteii:Kk 複合飲料
MY118354A (en) 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds
GB9509764D0 (en) 1995-05-15 1995-07-05 Tillotts Pharma Ag Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids
WO1999022719A1 (fr) * 1997-10-30 1999-05-14 Morishita Jintan Co., Ltd. Preparation de capsule contenant un acide gras insature ou un derive de celui-ci, et procede de fabrication
KR100587551B1 (ko) * 1997-12-10 2006-06-08 싸이클로스포린 테라퓨틱스 리미티드 오메가-3 지방산 오일을 함유하는 약학 조성물
EP1075252A2 (en) * 1998-05-07 2001-02-14 ELAN CORPORATION, Plc Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems
US20050037065A1 (en) * 1999-05-27 2005-02-17 Drugtech Corporation Nutritional formulations
ES2246769T3 (es) * 2000-05-22 2006-03-01 Pro Aparts - Investimentos E Consultoria Lda Composicion de acidos grasos que contiene al menos 80% en peso de epa y dha o sus derivados y su uso farmaceutico.
GB0210212D0 (en) * 2002-05-03 2002-06-12 Univ Southampton Effects of dietary N-3 and N-6 pufa intake on atheromatous plaque stability
BR0309740A (pt) 2002-05-03 2005-02-22 Pronova Biocare As Uso de ácido eicosapentaenóico (epa), ácido docosaexaenóico (dha) ou de uma mistura de epa e dha ou de um sal ou derivado farmaceuticamente aceitáveis dos mesmos
SE0202188D0 (sv) 2002-07-11 2002-07-11 Pronova Biocare As A process for decreasing environmental pollutants in an oil or a fat, a volatile fat or oil environmental pollutants decreasing working fluid, a health supplement, and an animal feed product
US20040254357A1 (en) 2002-12-19 2004-12-16 Zaloga Gary P. Fatty acid phenolic conjugates
SE0303513D0 (sv) * 2003-12-19 2003-12-19 Pronova Biocare As Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof
GB0403247D0 (en) * 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
GB0413730D0 (en) * 2004-06-18 2004-07-21 Tillotts Pharma Ag A pharmaceutical composition and its use
GB0413729D0 (en) * 2004-06-18 2004-07-21 Tillotts Pharma Ag A pharmaceutical composition and its use
KR101352299B1 (ko) 2004-06-28 2014-02-17 벨로시스 파마슈티컬스 에이/에스 액상 제형용 담체로서의 다공성 정제
US20060051462A1 (en) * 2004-09-03 2006-03-09 Wang Jimmy X Self emulsifying compositions for delivering lipophilic coenzyme Q10 and other dietary ingredients
KR101465715B1 (ko) * 2005-07-08 2014-11-27 모치다 세이야쿠 가부시키가이샤 심혈관 이벤트 발병 예방용 조성물
EP2364701A1 (en) * 2005-12-20 2011-09-14 Cenestra, Llc Omega-3 fatty acid formulations
CA2641852A1 (en) 2006-02-10 2007-08-16 Sportscom Danmark Aps Coated tablets, their methods of preparation, and related uses
MY153288A (en) * 2006-06-28 2015-01-29 Hovid Berhad An effective pharmaceutical carrier for poorly bioavailable drugs
EP2136844B1 (en) * 2007-03-20 2018-10-31 SCF Pharma Inc. Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
CA2692394A1 (en) * 2007-07-06 2009-01-15 Seth J. Baum Fatty acid compositions and methods of use
MY157189A (en) * 2008-01-10 2016-05-13 Takeda Pharmaceutical Capsule formulation
US20100062057A1 (en) * 2008-09-10 2010-03-11 Pronova BioPharma Norge AS. Formulation
WO2010040012A1 (en) * 2008-10-01 2010-04-08 Martek Biosciences Corporation Compositions and methods for reducing triglyceride levels
US9532963B2 (en) * 2009-03-09 2017-01-03 Pronova Biopharma Norge As Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof
CA3059911C (en) * 2009-05-22 2022-01-11 Mochida Pharmaceutical Co., Ltd. Self-emulsifying composition of .omega.3 fatty acid
ES2661812T3 (es) * 2009-10-16 2018-04-04 Mochida Pharmaceutical Co., Ltd. Composiciones
KR101904388B1 (ko) * 2009-10-23 2018-10-05 프로노바 바이오파마 너지 에이에스 지방산 오일 혼합물의 코팅된 캡슐 및 정제

Similar Documents

Publication Publication Date Title
JP6151317B2 (ja) 脂肪酸油混合物の被覆型カプセル剤および錠剤
US11523999B2 (en) Compositions comprising a fatty aged oil mixture and a free fatty acid, and methods and uses thereof
JP2013537186A (ja) 脂肪酸油混合物と遊離脂肪酸とスタチンとを含む組成物
JP2013537185A (ja) 遊離酸の形のｅｐａおよびｄｈａを含む脂肪酸油混合物と界面活性剤とスタチンとを含む組成物
WO2013072767A1 (en) Compositions and preconcentrates comprising at least one salicylate and omega-3 fatty acid oil mixture
TW201311294A (zh) 含脂肪酸油混合物、界面活性劑與司它汀（ｓｔａｔｉｎ）的組成物